• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Digital Pathology Systems - Global Strategic Business Report Product Image

Digital Pathology Systems - Global Strategic Business Report

  • ID: 2531223
  • January 2015
  • Region: Global
  • 175 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Digital Pathology Systems in US$ Thousands. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 50 companies including many key and niche players such as:

- 3DHISTECH Ltd.
- AccelPath, Inc.
- Apollo PACS, Inc.
- Carl Zeiss AG
- Corista LLC

Note: Product cover images may vary from those shown

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
A Prelude
Impact of Economic Recession in Retrospect & the Road Ahead
Market Outlook
Developed Markets to Maintain their Dominance
Digital Pathology Systems See Fast Paced Growth in Emerging Nations
Analytics: A Fast Growing Segment
Key Issues Hampering the Wider Adoption of Digital Pathology Systems
The Future in Retrospect

2. MARKET DRIVERS, TRENDS & ISSUES
The Need for Automation in Tissue Analysis
Workflow Efficiencies: A Key Market Driver for Digital Pathology Systems
Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems
Need for Early Diagnosis Puts Focus on Digital Pathology
Clinical Research Continues to be Core Vertical for Digital Pathology
Technological Advances Ease Issues in Digital Pathology Adoption
Possibilities Ahead in Digital Pathology
Digital Pathology Systems Continue to Widen their Scope
Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases
Move towards Hosted Technology: The New Fad
Digital Pathology as a Service Eludes Cost-based Issues
Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
Rising Emphasis on Lab Automation Extends Opportunity for Digital Pathology
Rising Penetration of Personalized Medicine Bodes Well for Digital Pathology
Increased Focus on Companion Diagnostics to Benefit the Market
Improving Healthcare & Research Expenditures Turbo Charge Digital Pathology
Table 1: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
Table 2: Top 20 Countries with the Highest Healthcare Spending as a Percentage of GDP (2012) (includes corresponding Graph/Chart)
Burgeoning Global Population: A Strong Business Case for Market Growth
Table 3: Top 25 Countries Worldwide in Terms of Population: 2007, 2010 & 2013 (includes corresponding Graph/Chart)
Aging Population: A Key Opportunity Indicator
Table 4: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
Table 5: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
Table 6: Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Table 7: Aging Population by Age Group in More Developed Countries (1975-2050) (includes corresponding Graph/Chart)
Table 8: Aging Population by Age Group in Less Developed Countries (1975-2050) (includes corresponding Graph/Chart)
Table 9: Aging Population by Age Group in Least Developed Countries (1975-2050) (includes corresponding Graph/Chart)
Table 10: Life Expectancy at Age 60 and 80 Years
(2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
Key Issues Hampering the Wider Adoption of Digital Pathology Systems
High Costs
Workflow Integration with Other Related Functions
Other Issues

3. COMPETITION
Leica Dominates the Market
Table 11: Leading Players in the Global Digital Pathology Systems Market (2013): Percentage Breakdown of Dollar Sales for Leica, Olympus, Roche/Ventana and Others (includes corresponding Graph/Chart)
Consolidation Rife in the Digital Pathology Space

4. PRODUCT OVERVIEW
An Introduction to Pathology
Digital Pathology: Computer-Enabled Pathology Process
Digital Pathology System: Components
Slide Scanners
Analytics
Storage
Communication
Applications
Remote Reviewing
Digital-Assisted Mathematical Analysis
Data Storage
Telepathology
Static Telepathology
Dynamic Telepathology
Hybrid Telepathology
Bio-banking
Multinational Integration
Tissue Microarray Analysis
A Review of Information Archival and Retrieval in Digital Pathology
Storage and Interoperability
Location and Internal Communication
Systems and Data Reliability
Image Life-Cycle Management
IT infrastructure and Management Costs
Factors Affecting Information Archival
Digital Pathology Management Systems
Benefits of Digital Pathology Systems
Easier Analysis and Archival & Retrieval of Digital Images
Access to Digital Slide Images Anytime Anywhere

5. PRODUCT INTRODUCTIONS/INNOVATIONS
Philips Obtains CE Mark Approval for Diagnostic Use of its Philips Digital Pathology Solution
Mikroscan Technologies Unveils Mikroscan L6 and the Mikroscan MC2 Telepathology Systems
Royal Philips Receives FDA 510(k) Clearance for Her2/neu IHC Digital Manual Read Product
Ventana Medical Systems Launches iScan HT Slide Scanner
Ventana Obtains FDA 510(k) Clearance for VENTANA Companion Algorithm Ki-67 (30-9) Image Analysis Solution

6. RECENT INDUSTRY ACTIVITY
Visiopharm Begins Operations in Benelux
Pixcelldata Selects Edge Solutions as its US Partner
CellNetix Pathology and Laboratories Merges with Highline Pathology Associates
Definiens Teams Up with Clarient Diagnostic Services
Pixcelldata Signs Partnership Deal with eX-Path
Pixcelldata Inks Partnership Agreement with Basys Data
IDEXX Laboratories Inks Collaboration Agreement with Royal Philips
Ventana Medical Systems and EMC Join Hands
XIFIN Acquires PathCentral
Kanteron Systems Signs Joint Selling & Marketing Agreement with DigiPath
DigiPath Inks New Agreement with Personalized Diagnostic
Dako to Launch Clinical Image Analysis for Digital Pathology
Ventana Medical Systems Inks Global Agreement with Barco
MEDITE Teams Up with UNIC Technologies
Leica Biosystems Takes Over Aperio Technologies
Carl Zeiss MicroImaging and Olympus America Sign Licensing Agreement
Aperio Technologies and Dell Enter into Strategic Collaboration
AccelPath Acquires DigiPath Solutions
Leica Microsystems and Indica Labs Sign Agreement
Omnyx™ Receives CE Mark in Europe
Erasmus MC Selects Philips to Adopt Digital Pathology System

7. FOCUS ON SELECT GLOBAL PLAYERS
3DHISTECH Ltd. (Hungary)
AccelPath, Inc. (US)
Apollo PACS, Inc. (US)
Carl Zeiss AG (Germany)
Corista LLC (US)
Definiens AG (Germany)
DigiPath Inc. (US)
Flagship Biosciences, LLC (US)
Koninklijke Philips Electronics N.V. (Netherlands)
Leica Microsystems GmbH (Germany)
MikroScan Technologies, Inc. (US)
Olympus America, Inc. (US)
Omnyx, LLC (US)
Pixcelldata Ltd. (Ireland)
Ventana Medical Systems, Inc. (US)
VMscope GmbH (Germany)

8. GLOBAL MARKET PERSPECTIVE
Table 12: World Recent Past, Current and Future Analysis for Digital Pathology Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 13: World Historic Review for Digital Pathology Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 14: World 15-Year Perspective for Digital Pathology Systems by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Current & Future Analysis
Market Overview
Increasing Pressure on Pathological Labs
An Opportunity in Disguise
Regulatory Scenario in the US
Health Insurance Portability and Accountability Act (HIPAA)
Food and Drug Administration (FDA)
Clinical Laboratory Improvement Amendments (CLIA)
Approval Status
Product Launches
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 15: US Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 16: US Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current & Future Analysis
Need for Digital Pathology in Canada
B.Market Analytics
Table 17: Canadian Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 18: Canadian Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current & Future Analysis
Digital Pathology in Japan
An Overview
B.Market Analytics
Table 19: Japanese Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 20: Japanese Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
B.Market Analytics
Table 21: European Recent Past, Current and Future Analysis for Digital Pathology Systems by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 22: European Historic Review for Digital Pathology Systems by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 23: European 15-Year Perspective for Digital Pathology Systems by Geographic Region
Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)
4a. FRANCE
Market Analysis
Table 24: French Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 25: French Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Current & Future Analysis
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 26: German Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 27: German Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 28: Italian Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 29: Italian Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
B.Market Analytics
Table 30: UK Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 31: UK Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
4e. SPAIN
Market Analysis
Table 32: Spanish Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 33: Spanish Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
4f. RUSSIA
Market Analysis
Table 34: Russian Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 35: Russian Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A.Market Analysis
Current & Future Analysis
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 36: Rest of Europe Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 37: Rest of Europe Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Current & Future Analysis
Asia-Pacific: Gradually Embracing Telepathology
Market Exhibits Faster Growth
South Korea: Limited Adoption despite Adequate Networking Infrastructure
China: Static Telepathology Remains Popular
Inadequate Infrastructure Impedes Adoption of Digital Pathology in India
Strategic Corporate Development
B.Market Analytics
Table 38: Asia-Pacific Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 39: Asia-Pacific Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

6. LATIN AMERICA
Market Analysis
Table 40: Latin American Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 41: Latin American Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

7. REST OF WORLD
A.Market Analysis
Current & Future Analysis
Africa: Digital Pathology finds Few Takers
B.Market Analytics
Table 42: Rest of World Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 43: Rest of World Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 50 (including Divisions/Subsidiaries 54)
The United States (27)
Canada (4)
Japan (2)
Europe (19)
Germany (6)
The United Kingdom (1)
Spain (1)
Rest of Europe (11)
Asia-Pacific (Excluding Japan) (2)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

bioCSL Abbott Laboratories Ltd. Radiometer Limited Genfit Focus Diagnostics Inc. Genomic Health Inc.